AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Company
-0.61%45.521.4%$885.56m
JNJJohnson & Johnson
-0.74%137.490.7%$815.16m
MRKMerck & Co., Inc.
-0.97%73.200.6%$807.82m
PFEPfizer Inc.
-1.25%39.380.9%$798.16m
LLYEli Lilly and Company
-1.12%115.201.0%$696.30m
ABBVAbbVie, Inc.
-0.54%77.562.2%$385.63m
AZNAstraZeneca PLC Sponsored ADR
0.08%38.801.3%$247.97m
NVSNovartis AG Sponsored ADR
-1.16%76.400.2%$242.29m
GSKGlaxoSmithKline plc Sponsored ADR
-0.30%39.860.2%$101.53m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.25%48.390.1%$65.24m
SNYSanofi Sponsored ADR
0.54%41.310.2%$39.69m
LCILannett Company, Inc.
1.71%7.1536.7%$7.95m
AKTXAkari Therapeutics Plc Sponsored ADR
0.32%3.121.6%$0.76m
EPIXESSA Pharma Inc
-9.17%2.290.1%$0.03m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.